BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA | Patent Publication Number 20230270786

US 20230270786 A1
Patent Number-
Application Number18175347
Filled DateFeb 27, 2023
Priority DateFeb 28, 2022
Publication DateAug 31, 2023
Original AssigneeNanjing Legend Biotech Co. Ltd.
Legend Biotech Usa Inc.
Johnson & Johnson
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsJordan SCHECTER
Xiaohu FAN
Michael HIRSCHMANN
Lida PACAUD
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.